Form D — Dash Bio, Inc.
0002041370-25-000002 · filed Jun 26, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- —
- Reported amount sold
- $10,999,976
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Dash Bio, Inc.
- CIK
- 2041370
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 56 BROAD STREET
BOSTON, Massachusetts 02109 - Phone
- 617-249-4472
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
DAVID JOHNSON · Executive OfficerBOSTON, Massachusetts Find on LinkedIn ↗
-
ALEXANDER TALLETT · Executive OfficerBOSTON, Massachusetts Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗